Magna International Inc. vs PACCAR Inc, two Auto Manufacturers stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
PACCAR earns 12.5% on equity building heavy trucks; Magna earns 6.46% supplying parts to the whole auto industry, the focused truck maker out-returning the diversified supplier by nearly double. PACCAR nets 8.91% of revenue to Magna's 1.97%, assembler margins against component ones. PACCAR runs debt-free (ex-finance), Magna carries 0.37 turns. PACCAR trades dearer, 25.7 times earnings against 22, but yields less free cash, 5.89% against Magna's 12.5%, and pays a smaller dividend, 2.25% against 3%. PACCAR earns the fatter margin and higher return on its focused niche while Magna yields more cash on diversified but thin supplier economics, and the market splits them by profitability.
Comparison updated 2026-07-11.
| Metric | MGA | PCAR |
|---|---|---|
| Price | $64.57 | $120.75 |
| Market cap | $18.2B | $63.7B |
| Sector | Auto Manufacturers | Auto Manufacturers |
| Stage | Mature | Mature |
| Implied growth (priced in) | +6.0% | +23.3% |
| P/E | 22.0 | 25.7 |
| P/B | 1.42 | 3.22 |
| P/S | 0.43 | 2.29 |
| EV/EBITDA | 13.8 | 77.4 |
| Revenue growth | +3.9% | -14.0% |
| Net margin | 2.0% | 8.9% |
| Return on equity | 6.5% | 12.5% |
| Return on assets | 2.6% | 5.7% |
| FCF yield | 12.5% | 5.9% |
| Dividend yield | 3.0% | 2.3% |
| Debt / equity | 0.37 | 0.00 |
| Current ratio | 1.25 | — |
| Altman Z (solvency) | 2.47 | 7.25 |
| Piotroski F (quality) | 6 / 9 | 8 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.